Global Filgrastim Biosimilars Market
Global Filgrastim Biosimilars Market Research Report 2023: Focus on Zarxio, Nivestym, and Releuko
02 mai 2023 06h03 HE | Research and Markets
Dublin, May 02, 2023 (GLOBE NEWSWIRE) -- The "Filgrastim Biosimilars Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.The global filgrastim biosimilars market...
22157.jpg
Worldwide Filgrastim Industry to 2027 - An Increase in the Aging Population is Driving Growth
21 janv. 2022 04h29 HE | Research and Markets
Dublin, Jan. 21, 2022 (GLOBE NEWSWIRE) -- The "Global Filgrastim Market By Drug Type, By Indication, By Distribution Channel, By Regional Outlook, Industry Analysis Report and Forecast, 2021 - 2027"...
22157.jpg
Global $880 Million Pegfilgrastim Biosimilars Markets, 2015-2020, 2020-2025F, 2030F
25 oct. 2021 04h18 HE | Research and Markets
Dublin, Oct. 25, 2021 (GLOBE NEWSWIRE) -- The "Pegfilgrastim Biosimilars Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's offering....
22157.jpg
Global $1.04 Bn Filgrastim Biosimilars Markets, 2015-2020, 2020-2025F, 2030F
20 oct. 2021 04h13 HE | Research and Markets
Dublin, Oct. 20, 2021 (GLOBE NEWSWIRE) -- The "Filgrastim Biosimilars Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's offering. The...
22157.jpg
Global Myelodysplastic Syndrome Treatment Drugs Market (2021 to 2029) - Featuring Bayer, Celgene and Incyte Among Others
17 juin 2021 07h58 HE | Research and Markets
Dublin, June 17, 2021 (GLOBE NEWSWIRE) -- The "Myelodysplastic Syndrome (MDS) Treatment Drugs Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players,...
22157.jpg
Global Filgrastim Biosimilars Market Report 2020: Due to COVID-19, the Market is Expected to Decline from $511.15 Million in 2019 to $445.04 Million in 2020
03 févr. 2021 04h48 HE | Research and Markets
Dublin, Feb. 03, 2021 (GLOBE NEWSWIRE) -- The "Filgrastim Biosimilars Global Market Report 2020-30: COVID-19 Growth and Change" report has been added to ResearchAndMarkets.com's offering. Major...
22157.jpg
Global Pegfilgrastim Biosimilars Market Report 2020: COVID-19 Growth and Change - Market to Decline by 15.2% and will Recover by 2023 - Forecast 2030
03 févr. 2021 03h58 HE | Research and Markets
Dublin, Feb. 03, 2021 (GLOBE NEWSWIRE) -- The "Pegfilgrastim Biosimilars Global Market Report 2020-30: COVID-19 Growth and Change" report has been added to ResearchAndMarkets.com's offering. Major...
22157.jpg
Global Filgrastim Biosimilars Market Opportunities and Strategies Report 2020-2030 Featuring Teva Pharma, Novartis International, Biocon, Intas Biopharmaceuticals, Dr. Reddy's Laboratories
14 janv. 2021 10h48 HE | Research and Markets
Dublin, Jan. 14, 2021 (GLOBE NEWSWIRE) -- The "Filgrastim Biosimilars Global Market Opportunities and Strategies to 2030: COVID-19 Implications and Growth" report has been added to...